Price-file publication check · 45 CFR § 180
B · 85
This hospital's published file contains most of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
9,471
Insurances with rates
23
CPT / HCPCS codes
7,978
Most expensive procedures (gross)
629
$51,643
OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH CC
Gross
$191,270
056
$32,478
DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MCC
Gross
$120,290
094
$30,649
BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITH MCC
Gross
$113,514
J2507
$24,187
PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION
Gross
$89,582
J9298
$19,530
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION
Gross
$72,332
288
$18,305
ACUTE AND SUBACUTE ENDOCARDITIS WITH MCC
Gross
$67,797
539
$17,663
OSTEOMYELITIS WITH MCC
Gross
$65,419
299
$14,972
PERIPHERAL VASCULAR DISORDERS WITH MCC
Gross
$55,451
J9144
$13,303
DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN
Gross
$49,272
J9217
$11,988
LEUPROLIDE ACETATE (6 MONTH) 45 MG INTRAMUSCULAR SYRINGE KIT
Gross
$44,399
J3380
$11,838
VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION
Gross
$43,843
500
$11,812
SOFT TISSUE PROCEDURES WITH MCC
Gross
$43,748
433
$10,839
CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH CC
Gross
$40,145
074
$10,111
CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MCC
Gross
$37,448
J9299
$10,059
NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION
Gross
$37,255
560
$9,669
AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC
Gross
$35,813
091
$8,000
OTHER DISORDERS OF NERVOUS SYSTEM WITH MCC
Gross
$29,631
306
$7,746
CARDIAC CONGENITAL AND VALVULAR DISORDERS WITH MCC
Gross
$28,689
J9271
$7,469
PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION
Gross
$27,662
637
$7,416
DIABETES WITH MCC
Gross
$27,467
559
$7,394
AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC
Gross
$27,384
947
$6,957
SIGNS AND SYMPTOMS WITH MCC
Gross
$25,767
149
$6,934
DYSEQUILIBRIUM
Gross
$25,683
896
$6,826
ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC
Gross
$25,281
950
$6,755
AFTERCARE WITHOUT CC/MCC
Gross
$25,017
305
$6,543
HYPERTENSION WITHOUT MCC
Gross
$24,232
593
$6,503
SKIN ULCERS WITH CC
Gross
$24,087
280
$6,414
ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC
Gross
$23,756
439
$6,411
DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH CC
Gross
$23,746
432
$6,408
CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MCC
Gross
$23,732
894
$6,280
ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA
Gross
$23,258
897
$6,234
ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC
Gross
$23,090
J3101
$6,096
TENECTEPLASE 50 MG INTRAVENOUS SOLUTION
Gross
$22,576
J0717
$6,070
CERTOLIZUMAB PEGOL 400 MG (200 MG X 2 VIALS) SUBCUTANEOUS KIT
Gross
$22,482
623
$6,052
SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH CC
Gross
$22,416
948
$5,880
SIGNS AND SYMPTOMS WITHOUT MCC
Gross
$21,779
698
$5,829
OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC
Gross
$21,589
832
$5,823
OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC
Gross
$21,567
561
$5,777
AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC
Gross
$21,395
096
$5,628
BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITHOUT CC/MCC
Gross
$20,844
J0775
$5,604
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 0.9 MG SOLUTION FOR INJECTION
Gross
$20,756
177
$5,564
RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC
Gross
$20,608
152
$5,525
OTITIS MEDIA AND URI WITH MCC
Gross
$20,463
949
$5,511
AFTERCARE WITH CC/MCC
Gross
$20,412
J9173
$5,439
DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION
Gross
$20,143
093
$5,398
OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT CC/MCC
Gross
$19,993
J3358
$5,368
USTEKINUMAB 130 MG/26 ML INTRAVENOUS SOLUTION
Gross
$19,883
065
$5,174
INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS
Gross
$19,164
638
$5,108
DIABETES WITH CC
Gross
$18,918
36837
$5,087
CAH PR Perq Av Fistula Creation Uxtr Sep Access Sites
Gross
$18,840
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 629 | OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH CC | $191,270 | $51,643 | — | — | 13 |
| 056 | DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MCC | $120,290 | $32,478 | — | — | 13 |
| 094 | BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITH MCC | $113,514 | $30,649 | — | — | 13 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $89,582 | $24,187 | — | — | 20 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $72,332 | $19,530 | — | — | 20 |
| 288 | ACUTE AND SUBACUTE ENDOCARDITIS WITH MCC | $67,797 | $18,305 | — | — | 13 |
| 539 | OSTEOMYELITIS WITH MCC | $65,419 | $17,663 | — | — | 13 |
| 299 | PERIPHERAL VASCULAR DISORDERS WITH MCC | $55,451 | $14,972 | — | — | 13 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $49,272 | $13,303 | — | — | 19 |
| J9217 | LEUPROLIDE ACETATE (6 MONTH) 45 MG INTRAMUSCULAR SYRINGE KIT | $44,399 | $11,988 | — | — | 20 |
| J3380 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $43,843 | $11,838 | — | — | 20 |
| 500 | SOFT TISSUE PROCEDURES WITH MCC | $43,748 | $11,812 | — | — | 13 |
| 433 | CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH CC | $40,145 | $10,839 | — | — | 12 |
| 074 | CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MCC | $37,448 | $10,111 | — | — | 13 |
| J9299 | NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION | $37,255 | $10,059 | — | — | 20 |
| 560 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC | $35,813 | $9,669 | — | — | 13 |
| 091 | OTHER DISORDERS OF NERVOUS SYSTEM WITH MCC | $29,631 | $8,000 | — | — | 13 |
| 306 | CARDIAC CONGENITAL AND VALVULAR DISORDERS WITH MCC | $28,689 | $7,746 | — | — | 13 |
| J9271 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $27,662 | $7,469 | — | — | 20 |
| 637 | DIABETES WITH MCC | $27,467 | $7,416 | — | — | 12 |
| 559 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC | $27,384 | $7,394 | — | — | 13 |
| 947 | SIGNS AND SYMPTOMS WITH MCC | $25,767 | $6,957 | — | — | 13 |
| 149 | DYSEQUILIBRIUM | $25,683 | $6,934 | — | — | 13 |
| 896 | ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC | $25,281 | $6,826 | — | — | 12 |
| 950 | AFTERCARE WITHOUT CC/MCC | $25,017 | $6,755 | — | — | 13 |
| 305 | HYPERTENSION WITHOUT MCC | $24,232 | $6,543 | — | — | 12 |
| 593 | SKIN ULCERS WITH CC | $24,087 | $6,503 | — | — | 12 |
| 280 | ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | $23,756 | $6,414 | — | — | 12 |
| 439 | DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH CC | $23,746 | $6,411 | — | — | 12 |
| 432 | CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MCC | $23,732 | $6,408 | — | — | 12 |
| 894 | ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA | $23,258 | $6,280 | — | — | 12 |
| 897 | ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC | $23,090 | $6,234 | — | — | 12 |
| J3101 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION | $22,576 | $6,096 | — | — | 20 |
| J0717 | CERTOLIZUMAB PEGOL 400 MG (200 MG X 2 VIALS) SUBCUTANEOUS KIT | $22,482 | $6,070 | — | — | 20 |
| 623 | SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH CC | $22,416 | $6,052 | — | — | 13 |
| 948 | SIGNS AND SYMPTOMS WITHOUT MCC | $21,779 | $5,880 | — | — | 13 |
| 698 | OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | $21,589 | $5,829 | — | — | 12 |
| 832 | OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC | $21,567 | $5,823 | — | — | 12 |
| 561 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC | $21,395 | $5,777 | — | — | 13 |
| 096 | BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITHOUT CC/MCC | $20,844 | $5,628 | — | — | 13 |
| J0775 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 0.9 MG SOLUTION FOR INJECTION | $20,756 | $5,604 | — | — | 19 |
| 177 | RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | $20,608 | $5,564 | — | — | 12 |
| 152 | OTITIS MEDIA AND URI WITH MCC | $20,463 | $5,525 | — | — | 12 |
| 949 | AFTERCARE WITH CC/MCC | $20,412 | $5,511 | — | — | 13 |
| J9173 | DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION | $20,143 | $5,439 | — | — | 20 |
| 093 | OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT CC/MCC | $19,993 | $5,398 | — | — | 13 |
| J3358 | USTEKINUMAB 130 MG/26 ML INTRAVENOUS SOLUTION | $19,883 | $5,368 | — | — | 19 |
| 065 | INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS | $19,164 | $5,174 | — | — | 12 |
| 638 | DIABETES WITH CC | $18,918 | $5,108 | — | — | 12 |
| 36837 | CAH PR Perq Av Fistula Creation Uxtr Sep Access Sites | $18,840 | $5,087 | — | — | 19 |
Showing top 50 of 9,471 priced procedures, sorted by gross charge.
Data straight from this hospital's own published price file (45 CFR § 180). The grade scores how completely the file contains the six required data elements. It is a check of the file — not a CMS compliance ruling, and not a measure of quality of care.